Back
Cara Therapeutics Vs. Golar LNG Industry Stock Comparison
Sell
16
CARA
Cara Therapeutics
Last Price:
0.29
Seasonality Move:
-6.01%
Buy
63
GLNG
Golar LNG
Last Price:
39.53
Seasonality Move:
1.01%
Sell
16
Cara Therapeutics (CARA)
is a Sell
Is Cara Therapeutics a Buy, Sell or Hold?
- The current Cara Therapeutics [CARA] share price is $0.29. The Score for CARA is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- CARA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
63
Golar LNG (GLNG)
is a Buy
Is Golar LNG a Buy, Sell or Hold?
- The current Golar LNG [GLNG] share price is $39.51. The Score for GLNG is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- GLNG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CARA Stock Price Chart
What is Cara Therapeutics's stock price today?
-
The Cara Therapeutics share price today is $0.29
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CARA is experiencing selling pressure, which indicates risk of future bearish movement.
CARA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 44.9 | Sell |
| Chaikin Money Flow: | -324806 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.27 - 0.33) | Sell |
| Bollinger Bands (100): | (0.27 - 0.35) | Sell |
GLNG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.39 | Buy |
| Relative Strength Index (14 RSI): | 60.36 | Buy |
| Chaikin Money Flow: | -1385452 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.18 - 38.4) | Buy |
| Bollinger Bands (100): | (32.67 - 37.47) | Buy |
CARA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.3 | Sell |
| 20-day SMA: | 0.31 | Sell |
| 50-day SMA: | 0.29 | Buy |
| 200-day SMA: | 0.51 | Sell |
| 8-day EMA: | 0.3 | Sell |
| 20-day EMA: | 0.3 | Sell |
| 50-day EMA: | 0.3 | Sell |
| 200-day EMA: | 0.69 | Sell |
GLNG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.73 | Buy |
| 20-day SMA: | 36.7 | Buy |
| 50-day SMA: | 36.89 | Buy |
| 200-day SMA: | 30.17 | Buy |
| 8-day EMA: | 37.73 | Buy |
| 20-day EMA: | 37.03 | Buy |
| 50-day EMA: | 36.32 | Buy |
| 200-day EMA: | 31.52 | Buy |
Cara Therapeutics Earnings Growth & CARA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $0.50 per share.
Golar LNG Earnings Growth & GLNG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.83 per share, and an increase next year of $0.17 per share.
Cara Therapeutics Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Golar LNG Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||